Clinical Trial Update: Optical Coherence Tomography in Cerebral Amyloidosis

View source ↗

Summary

This ClinicalTrials.gov entry describes a study evaluating optical coherence tomography in cerebral amyloidosis, including Alzheimer’s disease and related demen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment
• Dementia
• Dementia with Lewy Bodies

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Alzheimer Disease, Dementia Alzheimers | Status: UNKNOWN